Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.

Bärenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp GF, Dudziak D, Nimmerjahn F (2011)


Publication Status: Published

Publication Type: Journal article

Publication year: 2011

Journal

Book Volume: 108

Pages Range: 18772-7

Journal Issue: 46

DOI: 10.1073/pnas.1111810108

Abstract

Maintenance of immunological tolerance is crucial to prevent development of autoimmune disease. The production of autoantibodies is a hallmark of many autoimmune diseases and studies in mouse model systems suggest that inhibitory signaling molecules may be important checkpoints of humoral tolerance. By generating humanized mice with normal and functionally impaired Fcγ receptor IIB (FcγRIIB) variants, we show that the inhibitory Fcγ-receptor is a checkpoint of humoral tolerance in the human immune system in vivo. Impaired human FcγRIIB function resulted in the generation of higher levels of serum immunoglobulins, the production of different autoantibody specificities, and a higher proportion of human plasmablasts and plasma cells in vivo. Our results suggest that the inhibitory FcγRIIB may be an important checkpoint of humoral tolerance in the human immune system.

Authors with CRIS profile

How to cite

APA:

Bärenwaldt, A., Lux, A., Danzer, H., Spriewald, B.M., Ullrich, E., Heidkamp, G.F.,... Nimmerjahn, F. (2011). Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo. Proceedings of the National Academy of Sciences of the United States of America, 108(46), 18772-7. https://dx.doi.org/10.1073/pnas.1111810108

MLA:

Bärenwaldt, Anne, et al. "Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo." Proceedings of the National Academy of Sciences of the United States of America 108.46 (2011): 18772-7.

BibTeX: Download